๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Preoperative chemotherapy for mesoblastic nephroma

โœ Scribed by Chan, K. L. ;Chan, K. W. ;Lee, C. W. ;Saing, Htut

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
245 KB
Volume
24
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis

A neonate with extensive stage I l l mesoblastic nephroma was confirmed at operation to have a tumor that was too infiltrative and too advanced for primary excision. The abdomen was closed after multiple biopsies. Vincristine (1.1 mg/m2) was given intravenously once a week for a total of eight doses. Repeat CT scan confirmed shrinkage of the tumor and a nephrectomy could be per-formed safely and the tumor removed at the second laparotomy. CT scan repeated 1 year later showed no recurrence. This case illustrates the effective use of a single drug pre-excision chemotherapy which allowed a nephrectomy for extensive stage Ill mesoblastic nephroma to be carried out safely.

๐Ÿ“œ SIMILAR VOLUMES

Preoperative chemotherapy for fungating
Preoperative chemotherapy for fungating breast cancer
โœ Dr. Anand Kumar; L. L. Shah; Sushila Khanna; N. N. Khanna ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 327 KB

Thirty cases of fungating breast cancer (stages 111 and IV) were treated preoperatively by combination chemotherapy using cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, and prednisone. Mastectomy was performed after 2 cycles of preoperative chemotherapy followed by 6 more cycles postopera

Preoperative chemotherapy for osteogenic
Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
โœ Gerald Rosen; Brenda Caparros; Andrew G. Huvos; Cynthia Kosloff; Anita Nirenberg ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 936 KB

Since June 1978, 57 patients with primary osteogenic sarcoma of an extremity were treated with highdose methotrexate (HDMTX) and citrovorum factor rescue (CFR), Adriamycin, and the combination of bleomycin, cyclophosphamide and dactinomycin (BCD) given for 4-16 weeks prior to definitive surgery. His